dc.contributor.advisor | Pieler, Tomas Prof. Dr. | de |
dc.contributor.author | Gupta, Shivangi | de |
dc.date.accessioned | 2013-01-22T15:49:21Z | de |
dc.date.available | 2013-01-30T23:50:58Z | de |
dc.date.issued | 2009-11-18 | de |
dc.identifier.uri | http://hdl.handle.net/11858/00-1735-0000-000D-F172-3 | de |
dc.identifier.uri | http://dx.doi.org/10.53846/goediss-3480 | |
dc.identifier.uri | http://dx.doi.org/10.53846/goediss-3480 | |
dc.identifier.uri | http://dx.doi.org/10.53846/goediss-3480 | |
dc.format.mimetype | application/pdf | de |
dc.language.iso | eng | de |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/ | de |
dc.title | Expression of SLC transporters in Chronic Lymphocytic Leukaemia cells and their interaction with cytostatics | de |
dc.type | doctoralThesis | de |
dc.title.translated | Expression of SLC transporters in Chronic Lymphocytic Leukaemia cells and their interaction with cytostatics | de |
dc.contributor.referee | Groß, Uwe Prof. Dr. | de |
dc.date.examination | 2009-10-12 | de |
dc.subject.dnb | 500 Naturwissenschaften | de |
dc.subject.gok | WA | de |
dc.description.abstracteng | Chronic Lymphocytic Leukaemia, CLL, is one
of the most common forms of leukaemia in the elderly. The treatment
regimen determines the outcome of patients with CLL and the
efficiency of this treatment is modulated by the concentration of
cancer treating drugs in cancer cells. Uptake transporters of the
SLC (solute carrier) family can help overcome chemoresistance by
the application of transporter-specific cytostatics. In the present
study, we investigated the expression of SLC transporters in six
lymphoma cell lines and in CLL patient samples. Five of the six
cell lines tested, as well as samples from CLL patients
demonstrated a higher expression of SLC22A1 (OCT1) than in healthy
lymphocytes. The uptake of the organic cation [3H]MPP into OCT1
stably transfected CHO cells was significantly inhibited by
irinotecan, mitoxantrone and paclitaxel. The Ki values as
determined using Dixon plot analyses were 1.71 | de |
dc.subject.topic | Mathematics and Natural Science | de |
dc.subject.ger | SLC transporters | de |
dc.subject.ger | CLL | de |
dc.subject.ger | OCT1 | de |
dc.subject.ger | Irinotekan | de |
dc.subject.ger | Paclitaxel | de |
dc.subject.eng | SLC transporters | de |
dc.subject.eng | CLL | de |
dc.subject.eng | OCT1 | de |
dc.subject.eng | Irinotecan | de |
dc.subject.eng | Paclitaxel | de |
dc.subject.bk | 42.17 | de |
dc.identifier.urn | urn:nbn:de:gbv:7-webdoc-2269-2 | de |
dc.identifier.purl | webdoc-2269 | de |
dc.identifier.ppn | 615492584 | de |